Abstract
Securing a Competitive Advantage in the Reverse Transcriptase Market
provides insight into customer behavior, brand warfare, pricing strategy, and
market growth potential in this complex and important market.
From a product strategy perspective, reverse transcriptase is critical because
it serves as an entry point into a supplier' s profitable kits and reagents (as
well as instrumentation) for the RT-PCR and real-time PCR markets. Dominance
in such an important market foothold can secure a key competitive advantage
for a supplier. However worthwhile, attaining and maintaining such a position
in the reverse transcriptase market is difficult due to the presence of
several key players. An effective competitive strategy requires a thorough and
nuanced understanding of market dynamics that this study is designed to
provide.
Based upon a 24-question survey of over 500 life scientist customers in the
North American market for reverse transcriptase, BioInformatics LLC uses
sophisticated statistical analysis, including a Brand Equity Assessment and
Van Westendorp Price Sensitivity Analysis, to provide a thorough and nuanced
analysis of market dynamics. Results highlight a set of strategic leverage
points to assist any competitor in maintaining dominance or gaining share in
the reverse transcriptase market.
Included in the report are
- Comparative assessment of each leading brand' s performance, both past and
future
- Breakdown of key elements that contribute to brand performance
- Examination of the relationship between price and performance
- Critical factors placing suppliers at risk for losing customers to
competitors
- Comprehensive assessment of market expectations
View Cart
